The US Food and Drug Administration (USFDA) has completed the audit of Jeevan Scientific Technology’s clinical pharmacology centre facility with one study specific observation (One 483). The company is working on addressing this observation within the stipulated timelines.
Earlier, USFDA had conducted an un-announced audit of the company’s clinical pharmacology centre facility. The purpose of this audit was to review the BA/BE studies. The auditors started the review on January 9, 2018 and completed on January 12, 2018.
Jeevan Scientific Technology (JST) provides a range of clinical research services for healthcare/pharmaceutical industries in India and internationally. Its clinical research services comprise bio-analytical, clinical data management, biostatistics and statistical programming, medical writing, pharmacovigilance, regulatory affairs, quality assurance, and project management services, as well as clinical operation and scientific writing services.
| Company Name | CMP |
|---|---|
| TCS | 2582.00 |
| Infosys | 1318.75 |
| HCL Tech. | 1434.00 |
| Wipro | 203.35 |
| Tech Mahindra | 1519.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: